A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis

Inclusion Criteria: * Subjects must present with a clinical diagnosis of stable (at least 3 months) plaque-type psoriasis. * Subjects with psoriasis involving 10 to 20% BSA, not including the face, scalp, groin, axillae and other intertriginous areas. * Subjects must have an IGA grade of 3 (moderate) at the Baseline Visit Exclusion Criteria: * Current diagnosis of unstable forms of psoriasis including guttate, erythrodermic, exfoliative or pustular psoriasis. * Other inflammatory skin disease that may confound the evaluation of the plaque psoriasis (e.g., atopic dermatitis, contact dermatitis, tinea corporis). * Presence of pigmentation, extensive scarring, or pigmented lesions or sunburn which could interfere with the rating of efficacy parameters. * History of psoriasis unresponsive to topical treatments. * History of organ transplant requiring immunosuppression, HIV, or other immunocompromised state.